UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K/A

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES AND EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): March 14, 2010

 

 

HANSEN MEDICAL, INC.

(Exact name of registrant as specified in charter)

 

 

 

Delaware   001-33151   14-1850535

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

800 East Middlefield Road

Mountain View, California 94043

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (650) 404-5800

 

 

Check the appropriate box below if the Form 8-K/A filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d)(3) Hansen Medical, Inc. (“Hansen”) is filing this amendment to its Current Report on Form 8-K, filed with the Securities and Exchange Commission on July 30, 2009, to disclose the appointment of Kevin Hykes to the Audit Committee of the board of directors of Hansen.

On July 30, 2009, Hansen filed a Current Report on Form 8-K to report that Kevin Hykes had been appointed to serve on Hansen’s board of directors effective July 28, 2009. At the time of his appointment, the board of directors had not yet determined the committees on which Mr. Hykes would serve. On March 14, 2010, the board of directors appointed Mr. Hykes to serve on the Audit Committee of the board of directors.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

 

H ANSEN M EDICAL , I NC .

(Registrant)

Date: March 17, 2010  

/s/    P ETER O SBORNE        

 

Peter Osborne

Interim Chief Financial Officer

Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Hansen Medical, Inc. (MM) 차트를 더 보려면 여기를 클릭.
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Hansen Medical, Inc. (MM) 차트를 더 보려면 여기를 클릭.